Garner Asset Management Corp »

Travere Therapeutics shares owned by Garner Asset Management Corp

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Garner Asset Management Corp from 13F filings

Historical chart of Garner Asset Management Corp investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Garner Asset Management Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Garner Asset Management Corp

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.8k 1.2k 8.16

More positions owned by Garner Asset Management Corp

Prospect Capital Corporation (PSEC)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Diversified Healthcare Tr Com Sh Ben Int (DHC)
Rmr Group Cl A (RMR)
Brunswick Corporation (BC)
Verizon Communications (VZ)
Amazon (AMZN)
Farmland Partners (FPI)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl C (GOOG)
Costco Wholesale Corporation (COST)

View all positions for Garner Asset Management Corp

Top funds holding Travere Therapeutics

Vanguard Group
Deutsche Bank Aktiengesellschaft
Kynam Capital Management
Jacobs Levy Equity Management
D. E. Shaw & Co
Bank of America Corporation
Goldman Sachs Group
Millennium Management
Emerald Advisers
Avidity Partners Management
Emerald Mutual Fund Advisers, Trust
Schonfeld Strategic Advisors
Barclays
Healthcare Of Ontario Pension Plan Trust Fund
Two Sigma Advisers

View all funds holding Travere Therapeutics